Sigma Pharmaceuticals Forecast, price target & analysts
Sigma Pharmaceuticals Target price 2026 - Analyst rating & recommendation
Sigma Pharmaceuticals Classifications & Recommendation
Sigma Pharmaceuticals Price Target
| Target Price | A$3.26 |
| Price | A$2.85 |
| Potential | |
| Number of Estimates | 16 |
| 16 Analysts have issued a price target Sigma Pharmaceuticals 2027 . The average Sigma Pharmaceuticals target price is A$3.26. This is higher than the current stock price. The highest price target is , the lowest is . | |
| A rating was issued by 19 analysts: 15 Analysts recommend Sigma Pharmaceuticals to buy, 4 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
| Analyst Estimates: Analysts believe that the Sigma Pharmaceuticals stock has an average upside potential 2027 of . Most analysts recommend the Sigma Pharmaceuticals stock at Purchase. |
Sales and Margin forecast 2027, 2028 to 2033
| Jun '26 |
2027 Estimates |
|
|---|---|---|
| Revenue Billion A$ | ??? | ??? |
| ??? | ??? | |
| Net Margin | ??? | ??? |
| ??? | ??? |
17 Analysts have issued a sales forecast Sigma Pharmaceuticals 2027 . The average Sigma Pharmaceuticals sales estimate is
. This is than the revenue of the last 12 months(TTM). The highest sales forecast is , the lowest is .This results in the following potential growth metrics:
17 Sigma Pharmaceuticals Analysts have issued a net profit forecast 2027. The average Sigma Pharmaceuticals net profit estimate is
. This is than the net profit for the last 12 months(TTM). The highest net profit forecast is , the lowest is .This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2027, 2028 to 2033
| Jun '26 |
2027 Estimates |
|
|---|---|---|
| Earnings Per Share A$ | ??? | ??? |
| ??? | ??? | |
| P/E | ??? | |
| EV/Sales | ??? |
17 Analysts have issued a Sigma Pharmaceuticals forecast for earnings per share. The average Sigma Pharmaceuticals EPS is
. This is than earnings per share in the financial year 2026. The highest EPS forecast is , the lowest is .This results in the following potential growth metrics and future valuations:
Sigma Pharmaceuticals...
Current Sigma Pharmaceuticals Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| ??? |
Locked
➜
Locked
|
Locked | ??? |
| ??? |
Locked
➜
Locked
|
Locked | ??? |
| ??? |
Locked
➜
Locked
|
Locked | ??? |
| ??? |
Locked
➜
Locked
|
Locked | ??? |
| ??? |
Locked
➜
Locked
|
Locked | ??? |
| ??? |
Locked
➜
Locked
|
Locked | ??? |
| ??? |
Locked
➜
Locked
|
Locked | ??? |
| Analyst Rating | Date |
|---|---|
|
Locked
???:
Locked
➜
Locked
|
??? |
|
Locked
???:
Locked
➜
Locked
|
??? |
|
Locked
???:
Locked
➜
Locked
|
??? |
|
Locked
???:
Locked
➜
Locked
|
??? |
|
Locked
???:
Locked
➜
Locked
|
??? |
|
Locked
???:
Locked
➜
Locked
|
??? |
|
Locked
???:
Locked
➜
Locked
|
??? |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
